| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
| 05/13/2004 | US20040088802 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 05/13/2004 | DE10332232A1 Heteroaryloxy-substituierte Phenylaminopyrimidine Heteroaryloxyphenoxyalkanecarboxylic substituted Phenylaminopyrimidine |
| 05/13/2004 | DE10251170A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10250082A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2504511A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | CA2504213A1 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2004 | CA2503119A1 Anti-infective biaryl compounds |
| 05/13/2004 | CA2502532A1 Quaternary ammonium compounds as muscarinic receptor antagonists |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/12/2004 | EP1418175A1 Respiratory syncytial virus replication inhibitors |
| 05/12/2004 | EP1417204A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 05/12/2004 | EP1417203A1 S-6-hydroxy-buspirone |
| 05/12/2004 | EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417200A2 Substituted 1h-dihydropyrazoles, their preparation and use |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417187A1 Aryl substituted thiazolidinones and the use thereof |
| 05/12/2004 | EP1417186A2 Heterocyclic aryl sulphonamides |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417177A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 05/12/2004 | EP1417176A1 Substituted anthranilamides for controlling invertebrate pests |
| 05/12/2004 | EP1417175A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates, their preparation and use |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1416797A1 Arthropodicidal anthranilamides |
| 05/12/2004 | EP1416796A1 Method for controlling particular insect pests by applying anthranilamide compounds |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1066267B1 Substituted phenyl uracils |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496365A Herbicidal heterocyclic compound |
| 05/12/2004 | CN1496363A Process for preparation of imidazole compounds |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495180A Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1495168A Intermediate for preparing pesticide |
| 05/12/2004 | CN1495165A Indane or indoline derivative |
| 05/12/2004 | CN1495164A Method for preparing chiral lactone |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149200C 2-[(dihydro)pyrazole-3'-oxymethoylene]aniline amide and its preparation and use |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149195C 5-HTIF agonists |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | US6734308 Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734303 Therapy for benign prostatic hyperplasia |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734176 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 05/11/2004 | CA2293708C Enzymatic kinetic resolution of an intermediate useful for preparing substituted tricyclics |
| 05/11/2004 | CA2136999C Peripheral vasodilating agent containing piperidine derivative as active ingredient |
| 05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
| 05/06/2004 | WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | WO2004037811A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037809A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037797A2 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | WO2004037794A1 Process for making pyrazole compounds |
| 05/06/2004 | WO2004037791A1 Inhibitors of glycogen synthase kinase 3 |
| 05/06/2004 | WO2004037789A2 Methylene urea derivatives as raf-kinase inhibitors |
| 05/06/2004 | WO2004037784A2 Pyrrolidones with anti-hiv activity |
| 05/06/2004 | WO2004037257A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 05/06/2004 | WO2004037253A1 Amorphous form of esomeprazole salts |
| 05/06/2004 | WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity |
| 05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |